KRAS c.37_38inv ;(p.G13P)

Variant ID: 12-25398281-CC-GG

NM_004985.3(KRAS):c.37_38inv;(p.G13P)

This variant was identified in 11 publications

View GRCh38 version.




Publications:


NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma.

Cell Reports
Ramakrishnan, Gopalakrishnan G; Parajuli, Parash P; Singh, Pura P; Friend, Creighton C; Hurwitz, Eric E; Prunier, Celine C; Razzaque, Mohammed S MS; Xu, Keli K; Atfi, Azeddine A
Publication Date: 2022-11-08

Variant appearance in text: KRAS: G13P
PubMed Link: 36351408
Variant Present in the following documents:
  • NIHMS1848910-supplement-2.xlsx, sheet 1
  • NIHMS1848910-supplement-2.xlsx, sheet 3
View BVdb publication page



Intraductal Carcinoma of the Prostate as a Cause of Prostate Cancer Metastasis: A Molecular Portrait.

Cancers
Pantazopoulos, Helen H; Diop, Mame-Kany MK; Grosset, Andrée-Anne AA; Rouleau-Gagné, Frédérique F; Al-Saleh, Afnan A; Boblea, Teodora T; Trudel, Dominique D
Publication Date: 2022-02-06

Variant appearance in text: KRAS: G13P
PubMed Link: 35159086
Variant Present in the following documents:
  • Main text
  • cancers-14-00820.pdf
View BVdb publication page



Intraductal Carcinoma of the Prostate as a Cause of Prostate Cancer Metastasis: A Molecular Portrait.

Cancers
Pantazopoulos, Helen H; Diop, Mame-Kany MK; Grosset, Andrée-Anne AA; Rouleau-Gagné, Frédérique F; Al-Saleh, Afnan A; Boblea, Teodora T; Trudel, Dominique D
Publication Date: 2022-02-06

Variant appearance in text: KRAS: G13P
PubMed Link: 35159086
Variant Present in the following documents:
  • Main text
  • cancers-14-00820.pdf
View BVdb publication page



Calibration-free NGS quantitation of mutations below 0.01% VAF.

Nature Communications
Dai, Peng P; Wu, Lucia Ruojia LR; Chen, Sherry Xi SX; Wang, Michael Xiangjiang MX; Cheng, Lauren Yuxuan LY; Zhang, Jinny Xuemeng JX; Hao, Pengying P; Yao, Weijie W; Zarka, Jabra J; Issa, Ghayas C GC; Kwong, Lawrence L; Zhang, David Yu DY
Publication Date: 2021-10-21

Variant appearance in text: KRAS: G13P
PubMed Link: 34675197
Variant Present in the following documents:
  • 41467_2021_26308_MOESM8_ESM.xlsx, sheet 1
View BVdb publication page



Oncogene Concatenated Enriched Amplicon Nanopore Sequencing for rapid, accurate, and affordable somatic mutation detection.

Genome Biology
Thirunavukarasu, Deepak D; Cheng, Lauren Y LY; Song, Ping P; Chen, Sherry X SX; Borad, Mitesh J MJ; Kwong, Lawrence L; James, Phillip P; Turner, Daniel J DJ; Zhang, David Yu DY
Publication Date: 2021-09-06

Variant appearance in text: KRAS: G13P
PubMed Link: 34482832
Variant Present in the following documents:
  • 13059_2021_2449_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



The origins and genetic interactions of KRAS mutations are allele- and tissue-specific.

Nature Communications
Cook, Joshua H JH; Melloni, Giorgio E M GEM; Gulhan, Doga C DC; Park, Peter J PJ; Haigis, Kevin M KM
Publication Date: 2021-03-22

Variant appearance in text: KRAS: G13P
PubMed Link: 33753749
Variant Present in the following documents:
  • 41467_2021_22125_MOESM4_ESM.xlsx, sheet 4
View BVdb publication page



Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases.

Cancer
Mack, Philip C PC; Banks, Kimberly C KC; Espenschied, Carin R CR; Burich, Rebekah A RA; Zill, Oliver A OA; Lee, Christine E CE; Riess, Jonathan W JW; Mortimer, Stefanie A SA; Talasaz, AmirAli A; Lanman, Richard B RB; Gandara, David R DR
Publication Date: 2020-07-15

Variant appearance in text: KRAS: G13P
PubMed Link: 32365229
Variant Present in the following documents:
  • Main text
  • CNCR-126-3219.pdf
View BVdb publication page



Immunophenotypes of pancreatic ductal adenocarcinoma: Meta-analysis of transcriptional subtypes.

International Journal Of Cancer
de Santiago, Ines I; Yau, Christopher C; Heij, Lara L; Middleton, Mark R MR; Markowetz, Florian F; Grabsch, Heike I HI; Dustin, Michael L ML; Sivakumar, Shivan S
Publication Date: 2019-08-15

Variant appearance in text: KRAS: G13P
PubMed Link: 30720864
Variant Present in the following documents:
  • Main text
  • IJC-145-1125.pdf
View BVdb publication page



A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative.

Oncotarget
Pishvaian, Michael J MJ; Joseph Bender, R R; Matrisian, Lynn M LM; Rahib, Lola L; Hendifar, Andrew A; Hoos, William A WA; Mikhail, Sam S; Chung, Vincent V; Picozzi, Vincent V; Heartwell, Craig C; Mason, Kimberly K; Varieur, Katelyn K; Aberra, Metasebia M; Madhavan, Subha S; Petricoin, Emanuel E; Brody, Jonathan R JR
Publication Date: 2017-10-13

Variant appearance in text: KRAS: G13P
PubMed Link: 29137355
Variant Present in the following documents:
  • oncotarget-08-83446-s002.xlsx, sheet 2
View BVdb publication page



Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors.

Scientific Reports
Mauro, Concetta Di CD; Pesapane, Ada A; Formisano, Luigi L; Rosa, Roberta R; D'Amato, Valentina V; Ciciola, Paola P; Servetto, Alberto A; Marciano, Roberta R; Orsini, Roberta Clara RC; Monteleone, Francesca F; Zambrano, Nicola N; Fontanini, Gabriella G; Servadio, Adele A; Pignataro, Giuseppe G; Grumetto, Lucia L; Lavecchia, Antonio A; Bruzzese, Dario D; Iaccarino, Antonino A; Troncone, Giancarlo G; Veneziani, Bianca Maria BM; Montuori, Nunzia N; Placido, Sabino De S; Bianco, Roberto R
Publication Date: 2017-08-24

Variant appearance in text: KRAS: G13P
PubMed Link: 28839232
Variant Present in the following documents:
  • 41598_2017_10062_MOESM1_ESM.pdf
View BVdb publication page



Master Regulators of Oncogenic KRAS Response in Pancreatic Cancer: An Integrative Network Biology Analysis.

Plos Medicine
Sivakumar, Shivan S; de Santiago, Ines I; Chlon, Leon L; Markowetz, Florian F
Publication Date: 2017-01

Variant appearance in text: KRAS: G13P
PubMed Link: 28141826
Variant Present in the following documents:
  • Main text
  • pmed.1002223.pdf
View BVdb publication page



The potential utility of re-mining results of somatic mutation testing: KRAS status in lung adenocarcinoma.

Cancer Genetics
Biernacka, Anna A; Tsongalis, Peter D PD; Peterson, Jason D JD; de Abreu, Francine B FB; Black, Candice C CC; Gutmann, Edward J EJ; Liu, Xiaoying X; Tafe, Laura J LJ; Amos, Christopher I CI; Tsongalis, Gregory J GJ
Publication Date: 2016-05

Variant appearance in text: KRAS: G13P
PubMed Link: 27068338
Variant Present in the following documents:
  • Main text
View BVdb publication page